This clinical trial aims to learn if there is a relationship between OWT/OB and IDA in nonpregnant women of reproductive age and its impact on iron supplementation. The main questions it aims to answer are: * Is there any independent association between overweight/obesity and iron deficiency anemia in nonpregnant women after controlling for potential confounding factors? * Does the effect of iron supplementation on iron status vary between overweight/obese and normal-weight nonpregnant women (as measured by multiple iron biomarkers)? Researchers will compare several biomarkers between the case and control groups after the intervention is given for 90 days. Participants will: * Visit the research center before the intervention given and after 90 days * Take daily iron-folic acid supplements for 90 days * Keep a diary of their supplement's intake
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of participants with Iron Deficiency Anemia (IDA)
Timeframe: From enrollment to the end of treatment at 90 days
Concentration of Hemoglobin
Timeframe: Day 0 (Before intervention) and Day 90 (After intervention)
Concentration of Ferritin
Timeframe: Day 0 (Before intervention) and Day 90 (After intervention)
Concentration of Hepcidin
Timeframe: Day 0 (Before intervention) and Day 90 (After intervention)
Overweight and obese prevalence
Timeframe: Day 0 (Before intervention) and Day 90 (After intervention)
Concentration of CRP
Timeframe: Day 0 (Before intervention) and Day 90 (After intervention)
Concentration of AGP-1
Timeframe: Day 0 (Before intervention) and Day 90 (After intervention)